Sirona Biochem Appoints Nigel Terrett to Board of Directors

Marketwired

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Nov 28, 2013) - November 28, 2013 - Sirona Biochem Corp. (TSX VENTURE:SBM)(OTCQX:SRBCF) announced today the appointment of Nigel Terrett to its Board of Directors.

"We are thrilled that Nigel Terrett has agreed to join the team," said Neil Belenkie, Chief Executive Officer of Sirona Biochem. "Nigel's background in implementing successful strategic plans in life sciences, and his existing in-depth knowledge of Sirona through his work as our Strategic Advisor, will be an asset to us as we move forward in the growth and expansion of our business."

Sirona Biochem also announces that Chris Verrico will be stepping down from the company's Board of Directors. The company would like to extend its thanks and gratitude for his contribution.

About Nigel Terrett

Nigel Terrett has held many leadership roles in the life sciences sector some of which include his role of Chief Strategic Officer of LifeLabs Inc., Chairman of the Board at Excelleris Technologies, Senior Vice President of MDS Diagnostics Inc., and CIO within MDS Health Group. More recently, Nigel has provided strategic advisory services to the Biotech industry.

Contact:
Antonia Issa
Communications Manager
Sirona Biochem Corp.
Phone: 1.604.282.6065
Email: aissa@sironabiochem.com

View Comments